γ-谷氨酰转肽酶在肝脏疾病诊断和预后中的意义  

The value of γ-glutamyl transpeptidase in the diagnosis and prognosis of liver diseases

作　　者：吴芳[1] 孙凤霞[1] 徐春军[1] 

机构地区：[1]首都医科大学附属北京中医医院感染科,北京100010

出　　处：《中华实验和临床感染病杂志（电子版）》2015年第5期45-49,共5页Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)

基　　金：北京市卫生系统高层次卫生技术人才培养计划(No.2013-3-024)

摘　　要：γ-谷氨酰转肽酶(GGT)存在于人体各组织器官中,血清中绝大多数GGT来源于肝脏。GGT是一种敏感性高而特异性较低的酶,常需联系其他指标综合分析提高临床实用性,正确认识GGT可以提高临床对肝脏疾病的诊断及预后判断的准确性,本文就GGT联合其他实验室指标在肝脏疾病诊断和预后转归方面进行了综述。Gamma-glutamyl transpeptidase is known to be present in various body organs and tissues, and serum GGT comes mostly from the liver. GGT is an enzyme that specificen low but sensitivity high, which often needs to carry on a comprehensive analysis in combination with other indicators to improve clinical utility. Getting a thorough Understanding of GGT can improve the accuracy of diagnosis and assessing prognosis of clinical liver diseases. In this paper, the value of GGT association with other laboratory indexes in diagnosis were reviewed and prognosis of liver disease were assessed.

关 键 词：Γ-谷氨酰转肽酶 肝脏疾病 诊断 预后 

分 类 号：R575[医药卫生—消化系统]